Project Grant HT94252410076
Award Date 2/1/24
Completion Date 1/31/26
Dollars Obligated $164K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- This $961,118 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The Johns Hopkins University to target gut bacterial androgen production in order to reverse abiraterone resistance in metastatic prostate cancer. The 3-year award, beginning September 1, 2024, will enable the university to conduct innovative scientific studies aimed at developing treatments to improve health outcomes for military...
- This $1,473,751 federal Project Grant award, issued on August 15, 2024 by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports research by The Johns Hopkins University to investigate the influence of the tumor immune microenvironment and microbiome on prostate cancer immunotherapy response in Black men. The 3-year research initiative aims to transform healthcare through innovative and impactful medical research focused...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $271,697 Project Grant to The Johns Hopkins University on Sep 1, 2024. The grant funds research to "TARGET GUT BACTERIAL ANDROGEN PRODUCTION TO REVERSE ABIRATERONE RESISTANCE IN METASTATIC PROSTATE CANCER". This research aims to develop new treatments for metastatic prostate cancer by investigating the role of gut bacteria in androgen production and resistance to certain cancer...
- The federal Project Grant award of $1,552,867.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The award supports advanced biomedical research focused on the early detection of endometrial carcinoma through cell enrichment and flow cytometry. The performance period runs from Sep 30, 2025 to Sep 29, 2028. As a leading federal research institution, Johns Hopkins has a demonstrated track record of...
- The federal Project Grant award of $610,059.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Johns Hopkins University to investigate "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis." The award period runs from July 1, 2025 to June 30, 2028 and aims to advance biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- This $232,878 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund research by The Johns Hopkins University to explore the role of epitranscriptomics in the evolution of neuroendocrine prostate cancer. The project will run from June 1, 2025 to May 31, 2027 and aims to advance scientific understanding of this medical condition and develop potential innovative solutions. As a leading federal contractor and grantee, Johns...
- This $484,013 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of "PSMA-TARGETED MULTIPARAMETRIC ULTRASOUND" research at The Johns Hopkins University. The award period runs from August 1, 2024 to July 31, 2026. The project aims to advance biomedical research and innovative medical solutions relevant to military personnel and the broader public. As a leading research institution, The...
- The Johns Hopkins University will provide research services totaling $1,216,646 under a Project Grant award from the Defense Health Agency. The award's stated purpose is to investigate the role of polyamine metabolism in advanced prostate cancer. The grant falls under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform military and public health care. Specifically, the program aims to develop medical solutions for battlefield...
- This $1,406,799 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research to develop real-time localization techniques using near-infrared fluorophores to guide robotic-assisted radical prostatectomy procedures. The 3-year award, running from August 1, 2024 to July 31, 2027, will enable Johns Hopkins to conduct innovative biomedical research to improve surgical outcomes and...
- This federal Project Grant award of $360,413.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by The Johns Hopkins University focused on early hepatic dissemination of pancreatic cancer. The research aims to evaluate the efficacy of systemic chemotherapy-enhanced alpha-particle radiotherapy as a treatment approach. The award has a performance period from November 1, 2024 to October 31, 2027. As a leading academic...